In contrast to irreversible inhibitors of MAO-A such as clorgyline, reversible inhibitors such as moclobemide are better tolerated and have been particularly efficacious in treating depression [19,20] and cognitive disorders [21] in the elderly. The gene discussed is MAOA; the disease is major depressive disorder.